Cardiac markers, especially Troponin I (cTnI) and Troponin T (cTnT), are critical measurements in acute coronary syndrome. Most authorities recommend that these measurements are carefully quality controlled. UKNEQAS-Cardiac Marker schemes meet the external quality assessment (EQA) requirements of members by providing monthly distributions of samples with clinically relevant levels of these markers.
UKNEQAS-Cardiac Markers is provided by a not-for-profit Health Service Scotland organisation. It is fully accredited by Clinical Pathology Accreditation (UK) Ltd (CPA) and is a full member of UKNEQAS. The cardiac troponin EQA schemes have been in operation since 1998.
The following EQA schemes are all CPA accredited: Laboratory Based Schemes: cTnI, cTnT, CKMB, Myoglobin, B-type Natriuretic Peptide (BNP) and NT-proB-type Natriuretic Peptide (NT-proBNP). Point of Care Schemes - cTnI, cTnT, CKMB, Myoglobin, BNP and NT-proBNP. We welcome new participants from any clinical/research laboratory or point of care provider. Please check the NEWS page for scheme communications. EQAS 2012, Edinburgh 24th - 26th September 2012. There are sessions on Cardiac Markers within the scientific program. The Scheme has moved to a new location please check the News Section for further details. If you do not participate at present and wish further information on the schemes we provide please contact us. Registered participants can access further information on the following via the members area.
To assess the schemes service to participants please answer relevant questionnaires when requested.
UK NEQAS Cardiac Markers United Kingdom National External Quality Assessment Service (UK NEQAS) is a Company Limited by Guarantee (No. 3012351) and a Registered UK Charity (No. 1044013)
UK NEQAS Cardiac Markers